- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/14 - Preparation from compounds containing heterocyclic oxygen
Patent holdings for IPC class C07D 213/14
Total number of patents in this class: 18
10-year publication summary
|
2
|
4
|
1
|
1
|
0
|
0
|
3
|
1
|
1
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7937 |
2 |
| Enanta Pharmaceuticals, Inc. | 435 |
2 |
| Roche Diagnostics Operations, Inc. | 1510 |
1 |
| Bayer Cropscience AG | 1983 |
1 |
| Dow AgroSciences LLC | 1214 |
1 |
| GW Research Limited | 182 |
1 |
| Hetero Research Foundation | 173 |
1 |
| Ludwig-Maximilians-Universitat Munchen | 340 |
1 |
| Novaled GmbH | 455 |
1 |
| Regents of the University of Minnesota | 2739 |
1 |
| Rutgers, The State University of New Jersey | 1934 |
1 |
| Southern Research Institute | 210 |
1 |
| The Board of Regents of the University of Texas System | 2234 |
1 |
| Corteva Agriscience LLC | 2702 |
1 |
| Padarn Therapeutics, Inc. | 5 |
1 |
| Arrepath, Inc. | 4 |
1 |
| Other owners | 0 |